MX9306679A - Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene. - Google Patents

Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene.

Info

Publication number
MX9306679A
MX9306679A MX9306679A MX9306679A MX9306679A MX 9306679 A MX9306679 A MX 9306679A MX 9306679 A MX9306679 A MX 9306679A MX 9306679 A MX9306679 A MX 9306679A MX 9306679 A MX9306679 A MX 9306679A
Authority
MX
Mexico
Prior art keywords
penems
methylene
substituted
derived
preparation
Prior art date
Application number
MX9306679A
Other languages
English (en)
Inventor
Nigel John Perryman Broom
Frank Peter Harrington
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MX9306679A publication Critical patent/MX9306679A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Ink Jet (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Se describen compuestos de la fórmula (I): donde R1 es hidrógeno o un grupo sustituyente orgánico; R2 es un sistema de anillos bicíclicos, heterocíclicos, fusionados, de la fórmula general: donde R4 y R5 son, independientemente, hidrógeno o uno o más sustituyentes que reemplazan átomos de hidrógeno o uno o más sustituyentes que reemplazan átomos de hidrógeno en el sistema de anillos mostrado; m es 2 o 3; p es cero, 1 o 2; y R3 es hidrógeno, un catión formador de sales, o un grupo formador de ésteres; y el símbolo / indica que el doble enlace puede encontrarse ya sea en la configuración E o Z.
MX9306679A 1992-10-29 1993-10-27 Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene. MX9306679A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929222700A GB9222700D0 (en) 1992-10-29 1992-10-29 Chemical compounds

Publications (1)

Publication Number Publication Date
MX9306679A true MX9306679A (es) 1994-04-29

Family

ID=10724235

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306679A MX9306679A (es) 1992-10-29 1993-10-27 Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene.

Country Status (35)

Country Link
US (3) US5602250A (es)
EP (1) EP0666862B1 (es)
JP (1) JP3488457B2 (es)
KR (1) KR100295710B1 (es)
CN (3) CN1044247C (es)
AP (1) AP438A (es)
AT (1) ATE191914T1 (es)
AU (1) AU687365B2 (es)
BR (1) BR1100542A (es)
CA (1) CA2147755C (es)
CZ (1) CZ293106B6 (es)
DE (1) DE69328436T2 (es)
DK (1) DK0666862T3 (es)
ES (1) ES2145064T3 (es)
FI (1) FI114638B (es)
GB (1) GB9222700D0 (es)
GR (1) GR3033448T3 (es)
HK (1) HK1012375A1 (es)
HU (1) HUT71467A (es)
IL (1) IL107431A (es)
MA (1) MA23017A1 (es)
MX (1) MX9306679A (es)
MY (1) MY117265A (es)
NO (1) NO306903B1 (es)
NZ (1) NZ257109A (es)
PH (1) PH30919A (es)
PL (1) PL177840B1 (es)
PT (1) PT666862E (es)
RU (1) RU2133750C1 (es)
SA (1) SA93140373B1 (es)
SI (1) SI9300574A (es)
SK (1) SK281870B6 (es)
TW (1) TW400332B (es)
WO (1) WO1994010178A1 (es)
ZA (1) ZA937993B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
GB9326248D0 (en) * 1993-12-23 1994-02-23 Smithkline Beecham Plc Pharmaceutical formulations
WO1995028935A1 (en) * 1994-04-25 1995-11-02 Smithkline Beecham Plc Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
US6472383B1 (en) 1994-04-25 2002-10-29 Smithkline Beecham P.L.C. Pharmaceutical formulations
US6969303B1 (en) * 1994-10-12 2005-11-29 Nextec, Inc. Method and composition for removing coatings which contain hazardous elements
AU2001225605A1 (en) * 2000-10-03 2002-04-15 Elena Alexandrovna Izakson Thiazine derivatives
KR100912324B1 (ko) 2001-09-14 2009-08-14 글락소 그룹 리미티드 호흡기 질환 치료용 펜에탄올아민 유도체
AR039475A1 (es) 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR039774A1 (es) 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
AR039476A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp Proceso para preparar derivados de 6-alquiliden penem
FR2844807B1 (fr) * 2002-09-23 2005-11-11 Rambach Alain Procede de detection de microorganismes resistants a la meticilline
JP2007501635A (ja) * 2003-05-16 2007-02-01 ワイス・ホールディングズ・コーポレイション β−ラクタマーゼ阻害剤中間体を合成するための方法
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
US8722884B2 (en) * 2005-12-01 2014-05-13 Verastem, Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
EP2316821A1 (en) * 2009-10-27 2011-05-04 Novartis AG Process for the manufacture of organic compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2541924A (en) * 1948-09-17 1951-02-13 Lilly Co Eli Synthesis of substituted imidazoles
GB1403841A (en) * 1973-03-22 1975-08-28 Ici Ltd Imidazo heterocyclic derivatives
US4137320A (en) * 1974-02-07 1979-01-30 Plantex, Ltd. Pharmaceutical compositions containing imidazo(2,1-b)thiazoles and process for reducing blood sugar levels therewith
DE2949167A1 (de) * 1978-12-08 1980-06-26 Ciba Geigy Ag Photographisches material fuer das silberfarbbleichverfahren
FI82471C (fi) * 1984-01-26 1991-03-11 Beecham Group Plc Foerfarande foer framstaellning av farmakologiskt aktiva 6-metylenpenemderivater.
US5015473A (en) * 1984-01-30 1991-05-14 Pfizer Inc. 6-(substituted)methylenepenicillanic and 6-(substituted)hydroxymethylpenicillanic acids and derivatives thereof
GB8518421D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB8518416D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
JP2000500443A (ja) 1995-11-08 2000-01-18 スミスクライン・ビーチャム・コーポレイション ３−フェニル−１−メチレンジオキシフェニル−インダン−２−カルボン酸誘導体の製造プロセス

Also Published As

Publication number Publication date
SA93140373B1 (ar) 2005-06-07
AP9300585A0 (en) 1993-10-31
AU687365B2 (en) 1998-02-26
CZ105395A3 (en) 1996-04-17
GB9222700D0 (en) 1992-12-09
FI952063A0 (fi) 1995-04-28
FI952063A (fi) 1995-06-27
DK0666862T3 (da) 2000-09-11
PH30919A (en) 1997-12-23
KR100295710B1 (ko) 2001-10-24
CN1089267A (zh) 1994-07-13
JPH08502504A (ja) 1996-03-19
HUT71467A (en) 1995-11-28
KR950704332A (ko) 1995-11-17
NO951634D0 (no) 1995-04-28
CZ293106B6 (cs) 2004-02-18
IL107431A (en) 1999-05-09
US6600035B1 (en) 2003-07-29
CN1102595C (zh) 2003-03-05
MY117265A (en) 2004-06-30
SI9300574A (en) 1994-06-30
EP0666862B1 (en) 2000-04-19
JP3488457B2 (ja) 2004-01-19
US6037469A (en) 2000-03-14
CA2147755C (en) 2004-12-07
CN1143851C (zh) 2004-03-31
WO1994010178A1 (en) 1994-05-11
HK1012375A1 (en) 1999-07-30
ZA937993B (en) 1995-03-22
GR3033448T3 (en) 2000-09-29
DE69328436D1 (de) 2000-05-25
NO306903B1 (no) 2000-01-10
HU9501226D0 (en) 1995-06-28
ATE191914T1 (de) 2000-05-15
PL177840B1 (pl) 2000-01-31
FI114638B (fi) 2004-11-30
CN1227842A (zh) 1999-09-08
PT666862E (pt) 2000-08-31
CN1289766A (zh) 2001-04-04
IL107431A0 (en) 1994-01-25
SK54095A3 (en) 1995-09-13
US5602250A (en) 1997-02-11
TW400332B (en) 2000-08-01
ES2145064T3 (es) 2000-07-01
EP0666862A1 (en) 1995-08-16
CA2147755A1 (en) 1994-05-11
AU5335594A (en) 1994-05-24
SK281870B6 (sk) 2001-08-06
DE69328436T2 (de) 2000-10-19
CN1044247C (zh) 1999-07-21
PL308643A1 (en) 1995-08-21
RU95110049A (ru) 1997-01-10
NZ257109A (en) 1997-01-29
BR1100542A (pt) 2002-04-02
RU2133750C1 (ru) 1999-07-27
NO951634L (no) 1995-04-28
AP438A (en) 1995-11-24
MA23017A1 (fr) 1994-07-01

Similar Documents

Publication Publication Date Title
MX9306679A (es) Penems 6-(metilen-sustituidos), derivados de los mismos, proceso para su preparacion y composicion farmaceutica que los contiene.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
AR058967A2 (es) Derivados de triazolo[4,5-d] pirimidina composiciones farmaceuticas que los contienen y proceso de preparacion para dichos compuestos
ES2055056T3 (es) Derivados de pirimidopirimidina.
HUP9700328A2 (hu) Heteroaril-oxazolidinonok, eljárás előállításukra, a vegyületeket tartalmazó gyógyszerkészítmények, alkalmazásuk és köztitermékeik
AR048567A1 (es) Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas.
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
AR017189A1 (es) Antagonistas del receptor de trombina triciclico sustituido, composicion farmaceutica que lo contiene y su uso para la manufactura de un medicamento
DE60011269D1 (de) Azaidole mit serotonin rezeptor affinität
ES2071666T3 (es) Derivados de pirazoloisoquinolina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9400253A (es) Derivados de piperazina, proceso para su preparacion y composiciones farmaceuticas que los contienen.
FI903936A0 (fi) Saett att behandla hypertrofi och hyperplasi i hjaerta och blodkaerl.
DK178388A (da) Tricykliske aminer afledt af 2,3,5,6,7,8-hexahydronaphtho-(2,3-b)furan og af 2,3,6,7,8,9-hexahydro-5h-benzocyklohepta-(2,3-b)furan, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
ES2075004T3 (es) Derivados de pirimidina, procedimientos para su produccion y composiciones herbicidas que los contienen.
AR006497A1 (es) Pirimido[1,2-a]indoles, el uso de los mismos para la produccion de medicamentos, procedimiento para su produccion, medicamentos que loscontienen, acidos carboxilicos, procedimiento para su produccion
ATE252906T1 (de) Pharmazeutische formulierung, die ein beta- lactamase hemmendes penem in kombination mit einem beta-laktam-antibiotikum enthalten und ihre verwendung zur behandlung von bakteriellen infektionen
MX9306394A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
DK0555351T3 (da) Oxysulfonylcarbamater
ES415874A1 (es) Un procedimiento para preparar cefalosporinas.
ES2085787T3 (es) Compuestos de 1,2,3,4-oxatriazol-5-imina 3- y 5-sustituidos, un proceso para la preparacion de los mismos, un preparado farmaceutico que contiene tales compuestos y el uso de dichos compuestos en la preparacion de medicamentos.
AR007291A1 (es) Nuevos derivados de 10,11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida, metodo de preparacion y su uso en la preparacion de una composicion farmaceutica
NO305439B1 (no) Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse
GB872708A (en) Pyrrolo-[2, 1-ª-]-isoindoles and process for the production thereof
ECSP961980A (es) Compuestos de quinolina y quinazolina utiles en terapia

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees